Quiver Bioscience
Quiver Bioscience36
About
What does Quiver Bioscience do?
Quiver Bioscience is an AI-driven therapeutics company focused on accelerating the discovery of empirically grounded treatments for neurological diseases. They leverage a platform integrating scalable biology, advanced technology, and AI models to identify novel therapeutic targets and candidate molecules, aiming to deliver safer, more effective CNS drugs faster and at lower cost. Their approach utilizes patient-derived stem-cell models and all-optical electrophysiology to gain insights into com…
Where is Quiver Bioscience headquartered?
Quiver Bioscience is headquartered in Cambridge, Massachusetts, USA.
When was Quiver Bioscience founded?
Quiver Bioscience was founded in 2021.
What industry does Quiver Bioscience operate in?
Quiver Bioscience operates in Biotechnology, Pharmaceuticals, Rare Diseases, Genetics.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.